Table 1 Patient Treatments and Safety Outcome
From: Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety
Date of Birth | Date Treated | Total SVF Dose (x 106) & route of injection * | Side Effects |
|---|---|---|---|
|  |  | (SVF Dose × no. injections) |  |
6/24/1975 | 3/2/2010 | 128 IV (32 × 4) | Facial flushing, fever, myalgia (resolved after 3rd injection) |
1/15/1950 | 9/27/2010 | 120 IV (40 × 3) | None |
4/10/1954 | 5/26/2010 | 90 IV (30 × 3) | None |
7/4/1967 | 7/22/2010 | 60 IV (30 × 2) | None |
|  |  | 12 IA (6 × 2) |  |
11/29/1950 | 7/26/2010 | 60 IV (20 × 3) | None |
|  |  | 6 IA (6 × 1) |  |
7/3/1956 | 11/3/2010 | 60 IV (24 × 1, 18 × 2) | None |
6/1/1942 | 9/6/2010 | 90 IV (30 × 3) | None |
5/3/1940 | 4/26/2010 | 80 IV (40 × 2) | None |
|  |  | 32 IA (16 × 2) |  |
3/20/1941 | 8/11/2008 | 54 IV (27 × 2) | None |
3/25/1942 | 5/5/2008 | 108 IV (36 × 3) | None |
3/5/1963 | 2/26/2008 | 99 IV (33 × 3) | None |
1/15/1966 | 8/28/2008 | 90 IV (45 × 2) | None |
2/9/1952 | 9/30/2009 | 48 (30 × 1, 18 × 1) | None |